Objective: To evaluate a self-rated health measurement scale-the revised version 1.0 (SRHMS V1.0).Method:2000 subjects, including university students, patients in the department of traditional medicine, patients with dermatosis and military retired cadre, received the assessment with SRHMS V1.0. Result: The test-retest reliability of the above four groups was 0.80-0.98. The Cronbach alpha was 0.93, equal-length Spearman-Brown was 0.74, Guttaman Split-half was 0.73. The correlation between each item and its dimension was high, that between item and other dimension was low; furthermore, the correlation between each dimension and the subscale it belong to was high, that between the dimension and other subscales was low. Factor analysis produced ten main factors that were consistent with the original theoretical structure about SRHMS V1.0. The correlation between total score of SRHMS and that of SF-36 was significant (r=0.53). People of different age group, of different marriage status, with different occupations or education background, of different economic class had different results in SRHMS V1.0, while there was no difference significantly between male and female, between with different races or residencies. Conclusion: SRHMS V1.0 has good psychometric quality and can be used in Chinese population.

The neurofilament proteins (NFPs) from different neuronal tissues including Alzheimer and Huntington disease gray matter, rat brain gray, white matter and spinal cord were separated biochemically into two major fractions. A systematic investigation on the distribution, expression and phosphorylation of NFPs in those fractions was undertaken in the present study. It was found that only non-phosphorylated NF-H and NF-M, but not NF-L subunit were detected in Alzheimer brain gray matter high speed supernatant, whereas all neurofilament subunits including non-phosphorylated and phosphorylated were measured in high speed pellet fraction of the same tissue. The hyperphosphorylation of NF-H and NF-M in Alzheimer brain was shown by phosphorylation dependent monoclonal antibodies SMI31 and SMI34. This hyperphosphorylation was confirmed by non-phosphorylation dependent antibody SMI32 with dephosphosphorylation of the samples. Furthermore, an increased amount of NF-H, NH-M and NF-L, detected by SMI33 and NR4 respectively, was also observed in Alzheimer samples, in which the elevation in NF-L was significant. A significantly different immunoblot patterns in distribution, expression and phosphorylation were determined in various position of the neural system and alternative fractions. To our best knowledge, this is the first data shown definite abnormality of NFPs in Alzheimer disease. The information obtained in the present study will be extremely valuable in further study of the proteins both in physiological and pathological conditions.